{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T00:52:57Z","timestamp":1759539177633,"version":"build-2065373602"},"reference-count":45,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2004,3,1]],"date-time":"2004-03-01T00:00:00Z","timestamp":1078099200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2004,3,1]],"date-time":"2004-03-01T00:00:00Z","timestamp":1078099200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology"],"published-print":{"date-parts":[[2004,3]]},"DOI":"10.1016\/j.tox.2003.10.004","type":"journal-article","created":{"date-parts":[[2003,12,5]],"date-time":"2003-12-05T06:42:11Z","timestamp":1070606531000},"page":"197-209","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Short- and long-term effects of T-cell modulating agents in experimental autoimmunity"],"prefix":"10.1016","volume":"196","author":[{"given":"Johan","family":"Mellerg\u00e5rd","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Said","family":"Havarinasab","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Per","family":"Hultman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.tox.2003.10.004_BIB1","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1006\/cimm.1994.1034","article-title":"Interferon-gamma regulation of B lymphocyte differentiation: activation of B cells is a prerequisite for IFN-gamma-mediated inhibition of B cell differentiation","volume":"153","author":"Abed","year":"1994","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.tox.2003.10.004_BIB2","first-page":"307","article-title":"Cycloporin A induces long-term unresponsiveness in mercuric chloride-induced autoimmune glomerulonephritis","volume":"73","author":"Aten","year":"1988","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.tox.2003.10.004_BIB3","unstructured":"Bigazzi, P.E., 1998. Animal models of autoimmunity: spontaneous and induced. In: Rose, N.R., Mackay, I.R. (Eds.), The Autoimmune Diseases, Academic Press, San Diego, New York, pp. 211\u2013245."},{"key":"10.1016\/j.tox.2003.10.004_BIB4","first-page":"753","article-title":"Metals and kidney autoimmunity","volume":"107","author":"Bigazzi","year":"1999","journal-title":"Envirn. Health Perspect."},{"key":"10.1016\/j.tox.2003.10.004_BIB5","first-page":"S15","article-title":"How to outfox mother nature-autoimmunity: moving from shadows to sunshine","volume":"2","author":"Borchers","year":"2000","journal-title":"Isr. Med. Assoc. J."},{"key":"10.1016\/j.tox.2003.10.004_BIB6","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/j.1365-2249.1995.tb05574.x","article-title":"The effect of cyclosporin A, FK 506, and rapamycin on the murine chronic graft-versus-host response\u2014an in vivo model of Th2 like activity","volume":"99","author":"Bundick","year":"1995","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.tox.2003.10.004_BIB7","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s002960050014","article-title":"Xenobiotic immunosuppressive agents: therapeutic effects in animal models of autoimmune diseases","volume":"17","author":"Burkhardt","year":"1997","journal-title":"Rheumatol. Int."},{"key":"10.1016\/j.tox.2003.10.004_BIB8","doi-asserted-by":"crossref","first-page":"162","DOI":"10.4049\/jimmunol.168.1.162","article-title":"The CD8 T-cell compartment plays a dominant role in the deficiency of Brown-Norway rats to mount a proper type 1 immune response","volume":"168","author":"Cautain","year":"2002","journal-title":"J. Immunol."},{"key":"10.1016\/j.tox.2003.10.004_BIB9","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/0090-1229(90)90156-K","article-title":"Chronic in vivo depletion of CD4 T-cells increases both IgM levels and the expressed frequency of anti-ssDNA precursors in both NZB and DBA\/2 mice","volume":"56","author":"Cowdery","year":"1990","journal-title":"Clin. Immunol. Immunopathol."},{"key":"10.1016\/j.tox.2003.10.004_BIB10","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/0090-1229(92)90024-I","article-title":"In vivo depletion of CD4+ T-cells increases B-cell sensitivity to polyclonal activation: the role of interferon-gamma","volume":"62","author":"Cowdery","year":"1992","journal-title":"Clin. Immunol. Immunopathol."},{"key":"10.1016\/j.tox.2003.10.004_BIB11","doi-asserted-by":"crossref","first-page":"731","DOI":"10.2174\/0929867003374723","article-title":"FK506, an immunosuppressant targeting calcineurin function","volume":"7","author":"Dumont","year":"2000","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.tox.2003.10.004_BIB12","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1006\/clin.1993.1182","article-title":"Age influences recovery of systemic and mucosal immune responses following acute depletion of CD4+ T-cells","volume":"69","author":"Fleming","year":"1993","journal-title":"Clin. Immunol. Immunopathol."},{"key":"10.1016\/j.tox.2003.10.004_BIB13","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S1568-9972(02)00052-6","article-title":"Th2-type immunopathological manifestations induced by mercury chloride or gold salts in the rat: signal transduction pathways, cellular mechanisms, and genetic control","volume":"1","author":"Fourni\u00e9","year":"2002","journal-title":"Autoimm. Rev."},{"key":"10.1016\/j.tox.2003.10.004_BIB14","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1007\/BF00374076","article-title":"FK506: therapeutic effects on lupus dermatoses in autoimmune-prone MRL-lpr\/lpr mice","volume":"287","author":"Furukawa","year":"1995","journal-title":"Arch Derm Res."},{"key":"10.1016\/j.tox.2003.10.004_BIB15","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1002\/1098-2752(2000)20:8<420::AID-MICR13>3.0.CO;2-O","article-title":"Immunosuppressive agents in transplantation: mechanisms of action and current anti-rejection strategies","volume":"20","author":"Gorantla","year":"2000","journal-title":"Microsurgery."},{"key":"10.1016\/j.tox.2003.10.004_BIB16","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1006\/clin.1997.4336","article-title":"Murine strain differences in response to mercuric chloride: antinucleolar antibodies production does not correlate with renal immune complex deposition","volume":"83","author":"Goter Robinson","year":"1997","journal-title":"Clin. Immunol. Immunopathol."},{"key":"10.1016\/j.tox.2003.10.004_BIB17","first-page":"225","article-title":"Succesful treatment of autoimmunity in (NZB \u00d7 NZW) F1 mice with cyclosporin and (Nva2)-cyclosporin: 1. Reduction of autoantibodies","volume":"64","author":"Gunn","year":"1983","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.tox.2003.10.004_BIB18","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1046\/j.1365-2249.2003.02303.x","article-title":"Effects of deviating the Th2-response in murine mercury-induced autoimmunity towards a Th1-response","volume":"134","author":"H\u00e4ggqvist","year":"2003","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.tox.2003.10.004_BIB19","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1615\/CritRevImmunol.v20.i4.10","article-title":"Mechanisms of induction of tolerance to organ allografts","volume":"20","author":"Hall","year":"2000","journal-title":"Crit. Rev. Immunol."},{"key":"10.1016\/j.tox.2003.10.004_BIB20","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1046\/j.1365-2249.2002.01973.x","article-title":"Preclinical efficacy and safety of pascolizumab (SB 240683): a humanised anti-interleukin-4 antibody with therapeutic potential in asthma","volume":"130","author":"Hart","year":"2002","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.tox.2003.10.004_BIB21","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/0090-1229(92)90212-7","article-title":"Murine susceptibility to mercury. I. Autoantibody profiles and systemic immune deposits in inbred, congenic, and intra-H-2-recombinant strains","volume":"65","author":"Hultman","year":"1992","journal-title":"Clin. Immunol. Immunopathol."},{"key":"10.1016\/j.tox.2003.10.004_BIB22","first-page":"283","article-title":"The induction of immune-complex deposits in mice by peroral and parenteral administration of mercuric chloride","volume":"67","author":"Hultman","year":"1987","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.tox.2003.10.004_BIB23","first-page":"269","article-title":"Mercury induced antinuclear antibodies in mice: characterization and correlation with renal immune complex deposits","volume":"71","author":"Hultman","year":"1988","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.tox.2003.10.004_BIB24","first-page":"227","article-title":"Murine mercury-induced immune-complex disease: effect of cyclophosphamide treatment and importance of T-cells","volume":"70","author":"Hultman","year":"1989","journal-title":"Br. J. Exp. Pathol."},{"key":"10.1016\/j.tox.2003.10.004_BIB25","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/S0896-8411(95)80019-0","article-title":"Murine mercury-induced autoimmunity: the importance of T-cells","volume":"8","author":"Hultman","year":"1995","journal-title":"J. Autoimm."},{"key":"10.1016\/j.tox.2003.10.004_BIB26","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1006\/jaut.1996.0017","article-title":"Murine genotype influences the specificity, magnitude and persistence of murine mercury-induced autoimmunity","volume":"9","author":"Hultman","year":"1996","journal-title":"J. Autoimm."},{"key":"10.1016\/j.tox.2003.10.004_BIB27","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.4049\/jimmunol.119.6.2157","article-title":"Mechanism for induction of anti-DNA antibodies by bacterial lipopolysaccharides in mice. II. Correlation between anti-DNA induction and polyclonal antibody formation by various polyclonal B lymphocyte activators","volume":"119","author":"Izui","year":"1977","journal-title":"J. Immunol."},{"key":"10.1016\/j.tox.2003.10.004_BIB28","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1159\/000237619","article-title":"Murine silver-induced autoimmunity: silver shares induction of antinucleolar antibodies with mercury, but causes less activation of the immune system","volume":"113","author":"Johansson","year":"1997","journal-title":"Int. Arch. Allergy Immunol."},{"key":"10.1016\/j.tox.2003.10.004_BIB29","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1159\/000023959","article-title":"The genotype determines the B cell response in mercury-treated mice","volume":"116","author":"Johansson","year":"1998","journal-title":"Int. Arch. Allergy Appl. Immunol."},{"key":"10.1016\/j.tox.2003.10.004_BIB30","first-page":"1","article-title":"Prolongation of life in female NZB\/NZW (f1) hybrid mice by cyclosporin A","volume":"59","author":"Jones","year":"1985","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.tox.2003.10.004_BIB31","doi-asserted-by":"crossref","first-page":"234","DOI":"10.4049\/jimmunol.161.1.234","article-title":"Systemic autoimmunity indiced by mercury is dependent on IFN-gamma but not Th1\/Th2 imbalance","volume":"161","author":"Kono","year":"1998","journal-title":"J. Immunol."},{"key":"10.1016\/j.tox.2003.10.004_BIB32","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/0192-0561(93)90091-C","article-title":"Murine systemic autoimmune disease induced by mercuric chloride (HgCl2): Hg-specific helper T-cells react to antigen stored in macrophages","volume":"15","author":"Kubicka-Muranyi","year":"1993","journal-title":"Int. J. Immunopharmacol."},{"key":"10.1016\/j.tox.2003.10.004_BIB33","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1126\/science.1948049","article-title":"Generation and analysis of interleukin-4 deficient mice","volume":"254","author":"Kuhn","year":"1991","journal-title":"Science"},{"key":"10.1016\/j.tox.2003.10.004_BIB34","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/j.1365-2249.1992.tb03077.x","article-title":"Single and combined effects of the vitamin D analogue KH1060 and cyclosporin A on mercuric-chloride-induced autoimmune disease in the BN rat","volume":"88","author":"Lillevang","year":"1992","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.tox.2003.10.004_BIB35","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1146\/annurev.med.51.1.207","article-title":"Anti-cytokine therapy for rheumatoid arthritis","volume":"51","author":"Maini","year":"2000","journal-title":"Annl. Rev. Med."},{"key":"10.1016\/j.tox.2003.10.004_BIB36","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1002\/eji.1830191212","article-title":"Immunological alterations inducible by mercury compounds. III. H-2A acts as an immune response and H-2E as an immune \u201csuppression\u201d locus for HgCl2-induced antinucleolar antibodies","volume":"12","author":"Mirtcheva","year":"1989","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.tox.2003.10.004_BIB37","doi-asserted-by":"crossref","first-page":"S5877","DOI":"10.1289\/ehp.02110s5877","article-title":"Mercury-induced autoimmunity in mice","volume":"110","author":"Nielsen","year":"2002","journal-title":"Env. Health Perspect."},{"key":"10.1016\/j.tox.2003.10.004_BIB38","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0022-3565(24)37006-5","article-title":"FK-506 and cyclosporin A potentiate the IgE antibody production by contact sensitization with hapten in mice","volume":"283","author":"Nigai","year":"1997","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.tox.2003.10.004_BIB39","doi-asserted-by":"crossref","first-page":"3006","DOI":"10.4049\/jimmunol.146.9.3006","article-title":"Il-4 is required for the IgE and IgG1 increase and IgG1 autoantibody formation in mice treated with mercuric chloride","volume":"146","author":"Ochel","year":"1991","journal-title":"J. Immunol."},{"key":"10.1016\/j.tox.2003.10.004_BIB40","doi-asserted-by":"crossref","first-page":"750","DOI":"10.4049\/jimmunol.140.3.750","article-title":"Autoreactive T cells in mercury-induced autoimmune disease. Ability to induce the autoimmune disease","volume":"140","author":"Pelletier","year":"1988","journal-title":"J. Immunol."},{"key":"10.1016\/j.tox.2003.10.004_BIB41","doi-asserted-by":"crossref","first-page":"3521","DOI":"10.4049\/jimmunol.158.7.3521","article-title":"The autoimmunity-inducing xenobiotic mercury interacts with the autoantigen fibrillarin and modifies its molecular and antigenic properties","volume":"158","author":"Pollard","year":"1997","journal-title":"J. Immunol."},{"key":"10.1016\/j.tox.2003.10.004_BIB42","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.4049\/jimmunol.165.4.2263","article-title":"Proteolytic cleavage of a self-antigen following xenobiotic-induced cell death produces a fragment with novel immunogenic properties","volume":"165","author":"Pollard","year":"2000","journal-title":"J. Immunol."},{"key":"10.1016\/j.tox.2003.10.004_BIB43","doi-asserted-by":"crossref","first-page":"6644","DOI":"10.4049\/jimmunol.154.12.6644","article-title":"Differences in the degree of depletion, rate of recovery and the preferential elimination of naive CD4+ T-cells by anti-CD4 monoclonal antibody (GK1.5) in young and aged mice","volume":"154","author":"Rice","year":"1995","journal-title":"J. Immunol."},{"key":"10.1016\/j.tox.2003.10.004_BIB44","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/j.1600-065X.1992.tb01421.x","article-title":"Anti-CD4 monoclonal antibodies in therapy: creation of nonclassical tolerance in the adult","volume":"129","author":"Shizuru","year":"1992","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.tox.2003.10.004_BIB45","first-page":"222","article-title":"Experimental treatment of autoimmune MRL-lpr\/lpr mice with the immunosuppressive compound FK506","volume":"69","author":"Yamamoto","year":"1990","journal-title":"Immunology"}],"container-title":["Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300483X03004712?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300483X03004712?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T22:47:15Z","timestamp":1759531635000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0300483X03004712"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,3]]},"references-count":45,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2004,3]]}},"alternative-id":["S0300483X03004712"],"URL":"https:\/\/doi.org\/10.1016\/j.tox.2003.10.004","relation":{},"ISSN":["0300-483X"],"issn-type":[{"type":"print","value":"0300-483X"}],"subject":[],"published":{"date-parts":[[2004,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Short- and long-term effects of T-cell modulating agents in experimental autoimmunity","name":"articletitle","label":"Article Title"},{"value":"Toxicology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tox.2003.10.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2003 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}